| Engineering of an enhanced synthetic Notch receptor by reducing ligand-independent activation Z Yang, Z Yu, Y Cai, R Du, L Cai Communications Biology 3 (1), 116, 2020 | 50 | 2020 |
| Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells S Ly, V Anand, F El-Dana, K Nguyen, Y Cai, S Cai, H Piwnica-Worms, ... Journal for immunotherapy of cancer 9 (3), 2021 | 23 | 2021 |
| Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance F Li, Y Wang, I Hwang, JY Jang, L Xu, Z Deng, EY Yu, Y Cai, C Wu, Z Han, ... Nature communications 14 (1), 1756, 2023 | 6 | 2023 |
| Blockade of CD24 sensitizes pancreatic cancer to Kras inhibitors Y Wei, M Liu, EY Yen, J Yao, PT Nguyen, X Wang, Z Yang, A Yousef, ... Cancer Research 84 (6_Supplement), 6532-6532, 2024 | | 2024 |
| ATRX loss blocks the differentiation of mesenchymal stem cells and promotes undifferentiated sarcoma development Y Cai, J Yao, DN Pan, Y Jin, JM You, W Yao, H Ying Cancer Research 84 (6_Supplement), 3009-3009, 2024 | | 2024 |
| KRAS inhibition activates an actionable CD24 do-not-eat-me signal in pancreas cancer Y Wei, M Liu, EY Yen, J Yao, PT Nguyen, X Wang, Z Yang, A Yousef, ... bioRxiv, 2023.09. 21.558891, 2023 | | 2023 |
| De novo construction of mammalian synthetic inhibitory transcription factor and promoter pairs Z Yang, Y Pan, Y Cai, T Fu, A Feng, Y Liu, Y Wang, X Xiong, L Cai Sheng wu Gong Cheng xue bao= Chinese Journal of Biotechnology 34 (12), 1886-1894, 2018 | | 2018 |
